Skip to content
October 22, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
  • Home
  • Patient Advocacy and Support
  • A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Research
  • Patient Advocacy and Support

A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Research

Azzam Bilal Chamdy October 22, 2026 8 minutes read
a-global-beacon-for-the-forgotten-stage-325-landmarks-to-lightupmbc-for-metastatic-breast-cancer-research

NEW YORK, NY — As the world turns pink every October for Breast Cancer Awareness Month, a specific and often overlooked community is preparing to illuminate the night in a different palette. On October 13, 2026, more than 325 iconic landmarks across the globe will glow in teal, green, and pink. This synchronized display marks National Metastatic Breast Cancer Awareness Day, the cornerstone of the #LightUpMBC campaign spearheaded by METAvivor Research and Support.

While traditional breast cancer messaging frequently centers on early detection and the "battle won," the #LightUpMBC initiative aims to shine a harsh but necessary light on the reality of Stage 4 disease—a condition that currently has no cure. From the spire of One World Trade Center in New York to the mist of Niagara Falls and the terminals of Mactan-Cebu Airport in the Philippines, the world is being called to witness the lives of those living with metastatic breast cancer (MBC) and to fund the research required to save them.

Main Facts: A Global Call to Action

The #LightUpMBC campaign is not merely a visual tribute; it is a massive fundraising and educational engine. Metastatic breast cancer occurs when cancer cells break away from the primary tumor in the breast and travel through the lymphatic system or bloodstream to other parts of the body, most commonly the bones, liver, lungs, or brain. Once the cancer has reached this stage, it is classified as Stage 4.

The 2026 campaign represents the largest iteration of the event to date, spanning all 50 U.S. states and 20 countries. The choice of colors—teal, green, and pink—is deeply symbolic. Teal represents healing and spirituality; green symbolizes the triumph of spring over winter and the renewal of life; and pink signifies the disease’s origins in the breast. Together, they form the MBC awareness ribbon, a distinct departure from the universal pink ribbon that many patients feel does not represent the terminal nature of their diagnosis.

Central to the day’s activities is #LightUpMBC Live, a virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT. The program, which features a blend of patient testimonials, scientific updates, and world-class musical performances, serves as the primary vehicle for fundraising. METAvivor has confirmed that 100% of the net proceeds from the campaign are funneled directly into Stage 4 research grants.

Chronology: From a Single Bridge to a Global Movement

The meteoric rise of #LightUpMBC is a testament to the power of grassroots advocacy. The campaign’s origins are rooted in the personal tragedy and vision of Jessica Moore, a young woman diagnosed with MBC who passed away in 2017 at the age of 36.

  • 2017: The Spark. Jessica Moore expressed a simple wish: to see a local landmark lit in MBC colors to acknowledge those who would never be "done" with treatment. Following her passing, her best friend Laura Inahara worked to light the Memorial Bridge in Portsmouth, New Hampshire. It was the first landmark in the world to glow for MBC.
  • 2018–2020: Domestic Expansion. The movement began to catch fire across the United States. Advocacy groups and families of "METAvivors" (a term for those living with MBC) began petitioning their local city halls and bridges. By 2020, despite the global pandemic, the campaign transitioned into a digital-heavy format, launching the first #LightUpMBC Live stream to maintain momentum.
  • 2021–2025: International Recognition. The campaign crossed borders, reaching landmarks in Canada, the United Kingdom, and Ireland. The fundraising total surpassed $2 million, and the number of participating landmarks grew from dozens to hundreds.
  • 2026: The Global Apex. On October 13, 2026, the campaign reached its current scale. With over 325 landmarks, including the Willis Tower in Chicago and Ness Bridge in Scotland, the movement has evolved from a local tribute into a coordinated international diplomatic effort for health equity.

Supporting Data: The Stark Reality of Stage 4

The urgency behind #LightUpMBC is driven by statistics that remain sobering despite decades of general breast cancer awareness. According to data from the Surveillance, Epidemiology, and End Results (SEER) program, approximately 42,670 people in the United States are expected to die from breast cancer in 2026. This averages out to 117 deaths every single day.

Crucially, nearly all deaths from breast cancer are the result of metastasis. While early detection (Stage 0 through Stage 3) has seen significant improvements in five-year survival rates, the prognosis for Stage 4 remains a challenge.

  • The Diagnostic Gap: Some patients are "de novo" metastatic, meaning they are diagnosed at Stage 4 from the very beginning. Others may see their cancer return as metastatic disease years or even decades after being told they were "cancer-free."
  • The Funding Disparity: Historically, only a small fraction of breast cancer research funding (estimated by some advocacy groups to be between 7% and 15%) has been dedicated specifically to the metastatic stage, with the majority focused on prevention and early detection.
  • Treatment Longevity: For the MBC community, treatment is for life. Patients remain on chemotherapy, targeted therapies, or hormonal treatments until the cancer finds a way to bypass the medicine, at which point they must switch to a new line of treatment.

METAvivor’s role is to bridge this funding gap. By exclusively funding Stage 4 research, the organization ensures that the most brilliant scientific minds are focused on the mechanisms of metastasis and the development of therapies that can turn a terminal diagnosis into a manageable chronic condition.

Official Responses: Voices of Resilience and Science

The leadership of METAvivor and the founders of the campaign emphasize that while the lights are beautiful, the mission is survival.

Dr. Kelly Shanahan, METAvivor Board President, provides a unique perspective as both a physician and a patient. Diagnosed with MBC in 2013, Shanahan has outlived the median survival statistics, a feat she attributes directly to research. "When I was diagnosed… I certainly didn’t think I’d still be here 13 years later," Shanahan stated. "My hope and the hope of so many others lies in research. #LightUpMBC is the biggest contributor to this research, and is also a way to bring us together as a community."

Laura Inahara, #LightUpMBC Founder, reflected on the legacy of her friend Jessica Moore. "Jessica hoped to illuminate one local landmark. Today, her legacy helps families around the world shine a light for the people they love… and has now raised over $2.7 million for critical MBC research."

The 2026 live event is hosted by Tami Eagle Bowling, a creator and advocate who has lived with MBC for 11 years, alongside Broadway star Kara Lindsay. The inclusion of high-profile performers like Tony Award winner Victoria Clark and Dorian Harewood underscores the campaign’s success in garnering mainstream support for a cause that was once relegated to the shadows of the "pink ribbon" movement.

Implications: Changing the Paradigm of Breast Cancer

The #LightUpMBC campaign represents a fundamental shift in how the public perceives breast cancer. For decades, the narrative was one of "winning the war" and "ringing the bell" to signal the end of treatment. This narrative, while inspiring for many, often isolated those for whom there is no final treatment.

Shifting the Narrative

By focusing on October 13th as a distinct day of awareness, METAvivor is successfully carving out a space for the "Stage 4" conversation. This has significant psychological implications for patients, who often report feeling "pink-washed" or ignored during October. The campaign validates their experience, acknowledging that while they are living with cancer, they are not "dying" from it every day—they are actively advocating for more time.

Scientific Breakthroughs

The funds raised through #LightUpMBC have tangible outcomes. METAvivor’s rigorous peer-review process, which includes both scientists and patient advocates, ensures that grants are awarded to high-risk, high-reward projects that might be overlooked by larger, more conservative funding bodies. As more research is funded, the "toolbox" of treatments for MBC grows, leading to better quality of life and extended survival.

Global Solidarity

The participation of international landmarks like the Mactan-Cebu Airport and Ness Bridge highlights that MBC is a global health crisis. By creating a visual "chain of light" around the world, the campaign fosters a sense of international solidarity among patients who may feel alone in their local clinics.

Conclusion: How to Participate

As the sun sets on October 13, 2026, the public is encouraged to engage with the campaign beyond just viewing the lights. METAvivor has invited supporters to:

  1. Photograph: Capture images of participating landmarks in their cities.
  2. Share: Post photos to social media using the hashtags #LightUpMBC and #METAvivor, tagging @LightUpMBC.
  3. Watch: Tune into the live stream on the METAvivor YouTube or Facebook channels at 8 p.m. ET.
  4. Donate: Contributions can be made at www.lightupmbc.org, where every dollar is tracked toward the goal of funding the next breakthrough in metastatic research.

In a world that often looks away from the terminal reality of cancer, #LightUpMBC forces a moment of reflection. For one night, the world doesn’t just see pink; it sees the teal and green of a community that refuses to be forgotten, standing together in the glow of a future where Stage 4 is no longer a death sentence, but a life lived to the fullest.

About the Author

Azzam Bilal Chamdy

Author

View All Posts

Post navigation

Previous: Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Post-Treatment Survivorship Series

Related Stories

navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-post-treatment-survivorship-series
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Post-Treatment Survivorship Series

Neng Nana October 22, 2026
navigating-the-nexus-glp-1-medications-and-breast-cancer-what-the-latest-research-reveals
  • Patient Advocacy and Support

Navigating the Nexus: GLP-1 Medications and Breast Cancer – What the Latest Research Reveals

Dwi Wanna October 22, 2026
global-landmarks-to-glow-in-teal-green-and-pink-the-2026-lightupmbc-campaign-to-fund-critical-research
  • Patient Advocacy and Support

Global Landmarks to Glow in Teal, Green, and Pink: The 2026 #LightUpMBC Campaign to Fund Critical Research

Nila Kartika Wati October 22, 2026

Recent Posts

  • A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Research
  • Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Post-Treatment Survivorship Series
  • Roche Bolsters Oncology Pipeline with Landmark $400M Hansoh Pharma ADC Partnership
  • A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation
  • Bridging the Diagnostic Gap: Long-Read Sequencing Promises a New Era for Rare Disease Patients

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-global-beacon-for-the-forgotten-stage-325-landmarks-to-lightupmbc-for-metastatic-breast-cancer-research
  • Patient Advocacy and Support

A Global Beacon for the Forgotten Stage: 325 Landmarks to #LightUpMBC for Metastatic Breast Cancer Research

Azzam Bilal Chamdy October 22, 2026
navigating-the-new-normal-breast-cancer-canada-announces-comprehensive-post-treatment-survivorship-series
  • Patient Advocacy and Support

Navigating the "New Normal": Breast Cancer Canada Announces Comprehensive Post-Treatment Survivorship Series

Neng Nana October 22, 2026
roche-bolsters-oncology-pipeline-with-landmark-400m-hansoh-pharma-adc-partnership
  • Treatment Innovations

Roche Bolsters Oncology Pipeline with Landmark $400M Hansoh Pharma ADC Partnership

Azzam Bilal Chamdy October 22, 2026
a-new-dawn-for-reproductive-medicine-eight-healthy-infants-born-via-mitochondrial-donation
  • Genomics and Precision Medicine

A New Dawn for Reproductive Medicine: Eight Healthy Infants Born via Mitochondrial Donation

Dwi Wanna October 22, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.